quantum 
drug discovery
 

Partners

Partners

Partners

Partners

Rahko is solving drug discovery with quantum machine learning

Rahko is a quantum machine learning company cutting the cost and time to discover and develop new drugs. 

Drug discovery today is slow and expensive, limiting our ability to effectively and safely prevent and treat diseases.

Rahko brings together three technologies in its proprietary quantum discovery platform Hyrax: computational chemistry, machine learning and quantum computing. Hyrax enables faster and cheaper drug discovery with AI today, and discovery with significantly higher prediction accuracy using quantum computing tomorrow. 

Rahko is advised by several of the world’s leading scientists in quantum machine learning and machine learning for quantum chemistry, and backed by leading venture capital firms.

Rahko’s customers include several multinational pharmaceutical manufacturers and discovery CROs. Partners include AWS, IBM, Nvidia and Microsoft. 

Our Team

Leonard Wossnig

Chief Executive Officer and Co-founder

Edward Grant

Chief Science Officer and Co-founder

Miriam Cha

Chief Operating Officer and Co-founder

Ian Horobin

Executive Chairman and Co-founder

Prof Alexandre Tkatchenko

Professor of Theoretical Chemical Physics, University of Luxembourg

Prof Gábor Csányi

Professor of Molecular Modelling, University of Cambridge

Dr Cedric Weber

Snr Lecturer/Assoc Prof, King's College London

Dr George Booth

Reader in Theoretical Physics, King's College London

Prof Jonathan Tennyson

Professor of Physics, UCL / Chief Scientist, Quantemol / Founder, ExoMol

Prof Mike Payne

Chair of Computational Physics, Univ. of Cambridge

Peter Mountney

CEO, Odin Vision / Royal Society and UCL Entrepreneur in Residence

John Spindler

CEO, Capital Enterprise / CEO, AI Seed

Andy Martyn

Former CTO, Omnicision

Our Team

Leadership 

     

Leonard Wossnig

Chief Executive Officer and Co-founder

     

Edward Grant

Chief Science Officer and Co-founder

 

Miriam Cha

Chief Operating Officer and Co-founder

 

Ian Horobin

Executive Chairman and Co-founder

Advisors & Investors



Prof Alexandre Tkatchenko

Professor of Theoretical Chemical Physics, University of Luxembourg



Prof Gábor Csányi

Professor of Molecular Modelling, University of Cambridge



Prof Mike Payne

Chair of Computational Physics, Univ. of Cambridge



Dr George Booth

Reader in Theoretical Physics, King's College London

     

Prof jonathan Tennyson

Professor of Physics, UCL / Chief Scientist, Quantemol / Founder, ExoMol

     

Dr Cedric Weber

Snr Lecturer/Assoc Prof, King's College London

Research

  • arXiv

    Reduced Density Matrix Sampling: Self-consistent Embedding and Multiscale Electronic Structure on Current Generation Quantum Computers

    View Publication
  • arXiv

    A variational quantum eigensolver for dynamic correlation functions

    View Publication
  • arXiv

    Computation of molecular excited states on IBMQ using a Discriminative Variational Quantum Eigensolver

    View Publication
  • arXiv

    Machine learning logical gates for quantum error correction

    View Publication

Blog & News

Careers

Join our growing, multidisciplinary team. 

Contact us​

Sign up for updates 

The Coalface
Clifton House
46 Clifton Terrace
Finsbury Park
London N4 3JP